Will Kane

Mr. Will Kane is the Chief Commercial Officer of Karuna Therapeutics. He has more than 30 years of experience with product commercialization in the pharmaceutical industry and played an integral role in launching several successful brands, including CELEBREX® for the treatment of arthritis, NAMZARIC®‎ for Alzheimer’s disease, VRAYLAR® for the treatment of schizophrenia and bipolar disorder, and UBRELVY™, the first oral calcitonin gene-related peptide (CGRP) for the acute treatment of migraine.

Most recently, Mr. Kane served as the executive vice president and chief commercial officer at BioXcel Therapeutics. Prior to BioXcel, he’s held senior-level commercial positions at several other leading biopharma companies, including Allergan, Pfizer and Sepracor (now Sunovion Pharmaceuticals).

Mr. Kane received his bachelor’s degree in Government from Connecticut College and an M.B.A. from the Wharton School at the University of Pennsylvania.